SUBSCRIPTION AGREEMENTSubscription Agreement • February 12th, 2007 • Cornerstone Pharmaceuticals Inc • New York
Contract Type FiledFebruary 12th, 2007 Company JurisdictionSUBSCRIPTION AGREEMENT (this “Agreement”) made as of the last date set forth on the signature page hereof between Cornerstone Pharmaceuticals, Inc. (the “Company”), and Aaron Drillick and A. Joseph Stern the undersigned (individually each a Subscriber and Jointly the “Subscribers”). For all Units purchased jointly by Subscribers 85% shall be attributed to A. Joseph Stern and 15% shall be attributed to Aaron Drillick.
Employment AgreementEmployment Agreement • February 1st, 2008 • Cornerstone Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledFebruary 1st, 2008 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of September 1, 2007 and is effective as of August 22nd, 2007 (the “Effective Date”) by and between Cornerstone Pharmaceuticals, Inc., a New York corporation, with an office located at 1 Duncan Drive Cranbury NJ 08512 (the “Company”) and Clifford H. Straub, Jr. an individual with an address 24 Deerfield Road, Mendham, NJ 07945 (“[EMPLOYEE]”).
AMENDMENTAmendment • February 1st, 2008 • Cornerstone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 1st, 2008 Company Industry JurisdictionAmendment (this “Amendment”) dated as of this 15th day of August, 2007 to a certain Subscription Agreement (the “Agreement”), made and entered into as of January 22, 2007 between Cornerstone Pharmaceuticals, Inc. (the “Company”), and Aaron Drillick and A. Joseph Stern (individually each a “Subscriber” and Jointly the “Subscribers”).
SUBSCRIPTION AGREEMENTSubscription Agreement • February 1st, 2008 • Cornerstone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 1st, 2008 Company Industry JurisdictionSUBSCRIPTION AGREEMENT (this “Agreement”) made as of the last date set forth on the signature page hereof between Cornerstone Pharmaceuticals, Inc. (the “Company”), and Aaron Drillick and A. Joseph Stern the undersigned (individually each a Subscriber and Jointly the “Subscribers”). For all Units purchased jointly by Subscribers 85% shall be attributed to A. Joseph Stern and 15% shall be attributed to Aaron Drillick.